Lenvatinib and Impurities
Ref: 4Z-L-124032
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 19 Feb 2025
Ref: 4Z-L-124057
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 19 Feb 2025
Ref: 4Z-L-124024
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 19 Feb 2025
Ref: 4Z-L-124036
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 19 Feb 2025
Ref: 4Z-L-124060
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 19 Feb 2025
Ref: 4Z-L-124010
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 19 Feb 2025
Ref: 4Z-L-124063
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 19 Feb 2025
Lenvatinib
Controlled ProductCAS:417716-92-8
Applications Lenvatinib is an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF …
Formula:
C21H19ClN4O4
Color and Shape:
White To Beige
Molecular weight:
426.85
Ref: TR-L329400
5mg | 145.00 € | ||
25mg | 572.00 € | ||
100mg | 1,491.00 € |
Estimated delivery in United States, on Monday 24 Feb 2025